RBX2660 Shows Promise in Breaking the Cycle of Recurrent C d

Building on the success seen with fecal microbiota transplantation, this experimental treatment lowered the rates of recurrent C difficile infections.

Related Keywords

Minnesota , United States , New York , Mayo Clinic In Rochester , Sahil Khanna , Lisa Malter , American College Of Gastroenterology , Outstanding Research Award , Langone Health , Drug Administration Vaccines , Ferring Pharmaceuticals , Advisory Committee Nod , Products Advisory Committee , Mayo Clinic , Medscape Medical , American College , Scientific Meeting , Research Award , Drug Administration , Related Biological Products Advisory Committee , C Diff Infection , Clostridium Difficile Infection , Lostridium Difficile Associated Disease , C Diff Associated Disease , Crohns Disease , Diarrhea , Ulcerative Colitis , Irritable Bowel Syndrome Ibs , Irritable Bowel Syndrome , Jobs , Infectious Disease Diagnostics , Iagnostics Infectious Disease , Abdominal Pain , Inflammatory Bowel Disease , Nflammatory Bowel Disease Ibd , Bd , Pain Management , Ai ,